“National immunobiological company” will retain the status of sole supplier of vaccines
According to the decree of the RF government company “national immunobiological company” was authorized for the purchase of vaccines for immunization within the National vaccination calendar in 2020-2021 years. Thus, the company will retain the status of sole supplier of immunobiological preparations for inoculations netcalendar. At the disposal of the said powers shall apply only to supplies of the vaccine produced at all stages of the technological process on the territory of Russia.
As the General Director of “national immunobiological company” Andrey Zagorsky, in recent years, the company has confirmed the effectiveness and appropriateness of the work of the main contractor’s supply on the market of vaccines used for routine vaccination of the population. “We have introduced the idea of priority of supply, created an effective logistics system, expanded production in order to provide vaccines extensive network of contractors throughout the country”, – said Andrey Zagorsky.
In 2019 “national immunobiological company’s” first put tetravalent vaccine for prevention of flu, created on the basis of the enterprise, and also registered two new drug Pentavaccine (pathcomponent combined vaccine DTaP–HBV+Hib) and three-component vaccine for the simultaneous prevention of measles, rubella and mumps – Activir.
